Filter posts

Fresenius v. Baxter: BIO files Amicus Brief in Federal Circuit

The Biotechnology Industry Organization filed an amicus brief at the Federal Circuit in the case …

Bayh-Dole and Technology Transfer Continue to Deliver

The Association of University Technology Managers released the 2012 AUTM U.S. Licensing Activity Survey Highlights …

TPP and Innovation in the Bioeconomy: The Need for 12 Years of Data Protection

A few weeks ago, BIO submitted a letter and white paper (PDF) to the U.S. Trade Representative outlining recommendations …

Patent Docs Highlights the BIO IPDx Symposium

Patent Docs recently highlighted McDonnell Boehnen Hulbert & Berghoff’s (MBHB) panel at BIO’s IP and …

BIO IP & Diagnostics Symposium

BIO’s IP & Diagnostics Symposium (BIO IPDX) will review the current patent law landscape and …

BIO Joins Alliance for Fair Trade with India

BIO recently joined the Alliance for Fair Trade with India along with the U.S. Chamber …

MERS, Patents, and Material Transfer Agreements: What WHO Didn't Know

The outbreak of the Middle East Respiratory Syndrome (MERS-CoV), a SARS like virus has lead …

Myriad Supreme Court Decision: BIO’s Statement

Statement On U.S. Supreme Court Review Of Isolated DNA Patents Washington, D.C. (June 13, 2013) …

IP in Latin America: Growing Recognition of the Importance of IP to Innovation

The Inter-American Dialogue’s daily Latin America Advisor recently asked the question “How seriously do Latin …

Gene Patents, Angelina Jolie, and Reality

By Dr. Hans Sauer, J.D., Deputy General Counsel for Intellectual Property, Biotechnology Industry Organization  Angelina …